CCR4/CD194 cDNA Clones Research Reagents

All CCR4/CD194 reagents are produced in house and quality controlled, including 35 CCR4/CD194 Gene, 2 CCR4/CD194 qPCR. All CCR4/CD194 reagents are ready to use.
More Less

All CCR4/CD194 Reagents

CCR4/CD194 General Information

CCR4/CD194 cDNA Clone (35)

BC071751

In expression vector

untagged

C-GFPSpark N-DDK tag C-His tag C-HA tag C-Myc

In lentiviral vector

C-GFPSpark
NM_009916.2

In expression vector

untagged

In lentiviral vector

C-GFPSpark
NM_133532.2

In cloning vector

In cloning vector

In expression vector

untagged

C-GFPSpark C-OFPSpark C-DDK tag N-DDK tag C-His tag N-His tag C-HA tag N-HA tag C-Myc N-Myc

In lentiviral vector

C-GFPSpark
XM_001098807.2

In cloning vector

In cloning vector

In expression vector

untagged

C-GFPSpark C-OFPSpark C-DDK tag N-DDK tag C-His tag N-His tag C-HA tag N-HA tag C-Myc N-Myc

In lentiviral vector

C-GFPSpark

CCR4/CD194 qPCR Primer (2)

More Product Popular With Customers

CCR4/CD194 Background

CCR4 is a chemokine receptor that has a critical role in immune cell trafficking. T-helper type 2 cells (Th2), regulatory T cells (Treg), interluekin-17–producing T-helper cells (Th17), and skin-homing memory T cells express CCR4 on their surface and migrate toward the chemokines CCL17 and CCL22. CCR4, a C-C type chemokine receptor, has previously been focused on its biological function in immunopathogenesis of hematological tumors. To date, relatively little attention has been paid to the role of CCR4 in promoting metastasis of some solid tumors, including gastric cancer. Our group has shown that the lymphocyte-rich gastric cancers tend to be more frequently positive for CCR4, and found a novel role of CCR4 in tumor-induced immunosuppression, indicating various expression profiles of CCR4 in gastric cancer tissues and multifunctional roles of this molecule in gastric cancer progression.

CCR4/CD194 References

  • Yang Y, Du L, Yang X, et al. Aberrant CCR4 Expression Is Involved in Tumor Invasion of Lymph Node-Negative Human Gastric Cancer. Tang C-H, ed. PLoS ONE. 2015;10(3):e0120059. doi:10.1371/journal.pone.0120059.
  • Nakagawa M, Schmitz R, Xiao W, et al. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma. The Journal of Experimental Medicine. 2014;211(13):2497-2505.

Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.